SCHEMBL6675941

SCHEMBL6675941

CC(C)(C)OC(=O)N(Cc1cc(NC(N)=S)ccc1N1CCCCC1)C(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
RECQL P46063 1/20 0.43
NPSR1 Q6W5P4 7/20 0.42
ALDH1A1 P00352 7/20 0.40
S1PR1 P21453 1/20 0.40
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
CYP2C19 P33261 4/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
CYP2C9 P11712 3/20 0.38
KCNH2 Q12809 1/20 0.38
CYP2D6 P10635 2/20 0.38
NR1I3 Q14994 1/20 0.37
RAB9A P51151 2/20 0.37
NPC1 O15118 1/20 0.37
GAA P10253 2/20 0.36
MAPK1 P28482 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAPT P10636 3/20 0.36
ACHE P22303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6675178 0.99 KDM4E (0.44) KDM4ERECQLNPSR1ALDH1A1S1PR1
SCHEMBL6679310 0.86 KDM4E (0.40) KDM4ERECQLNPSR1ALDH1A1MEN1
SCHEMBL7739635 0.84 ALDH1A1 (0.37) ALDH1A1MEN1KMT2ACYP2C19SMN1; SMN2
SCHEMBL6678474 0.83 ALDH1A1 (0.39) ALDH1A1MEN1KMT2ACYP2C19SMN1; SMN2
SCHEMBL6675695 0.83 ALDH1A1 (0.39) ALDH1A1KMT2ACYP2C19SMN1; SMN2CYP2C9
SCHEMBL6679306 0.83 KDM4E (0.43) KDM4ERECQLNPSR1ALDH1A1MEN1
SCHEMBL6688371 0.83 KDM4E (0.41) KDM4ERECQLNPSR1ALDH1A1MEN1
SCHEMBL6678436 0.82 ALDH1A1 (0.40) ALDH1A1KMT2ARAB9ANPC1GAA
SCHEMBL6681804 0.82 GRM2 (0.38) ALDH1A1KMT2ASMN1; SMN2GAAMAPT
SCHEMBL6682248 0.81 ALDH1A1 (0.40) ALDH1A1KMT2ACYP2C19SMN1; SMN2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0798292-B1 ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY CHUGAI SEIYAKUKABUSHIKI KAISHA (JP) 2004-11-03 EP disclosed
US-6534546-B1 Guanidine- or isothioureido-N-derived anilines; brain, nervous system, and neurodegenerative disorders CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-18 US disclosed
EP-0798292-A1 ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY Chugai Seiyaku Kabushiki Kaisha (JP) 1997-10-01 EP disclosed